Thndr Claps
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic
No Result
View All Result
Thndr Claps

Thndr Claps » EGY Claps » IPO Watch 👀 » Macro Group Shares to List on EGX Database Today⚕

Macro Group Shares to List on EGX Database Today⚕

by Shams Abbas
January 13, 2022

The EGX has approved the listing of Macro Group Pharmaceuticals’ shares on its database. 

More Details🧐 In a first issue, EGP 115.47 million of Macro Group’s capital will be distributed over 577.36 million shares, with a par value of EGP 0.20/share. The shares will be listed today, January 13, 2022, under the ticker MCRO.

Why is this Important🤔 The listing of Macro Group’s shares on the EGX’s database does not mean the shares are tradable.  The FRA must first approve Macro’s prospectus, followed by the EGX’s approval for the start of trading, similar to Nahr Elkhair’s (KRDI) recent situation. Head of the FRA Mohamed Omran expects Macro Group to list on the EGX by January 23rd, 2022.

It’s worth noting that KRDI is expected to begin trading as soon as it receives the green light from the FRA on its prospectus. KRDI is eligible to skip the IPO process & list its shares in a direct listing because it has 466 current shareholders, meeting the minimum criteria of 300 shareholders to skip the IPO process. Osoul Arabia Financial Consultants acting as independent financial advisors for KRDI’s listing. 

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Related Posts

HCCD negotiating with Gulf authorities to sell lands
Health & Pharma💉

B Investments & the Sovereign Fund of Egypt ready to invest in healthcare

by Shams Abbas
January 24, 2023
EGX 🔔

CI Capital plans to co-establish new equity fund

by Shams Abbas
January 23, 2023
EGX 🔔

EGX Chairman discusses upcoming developments

by Shams Abbas
January 22, 2023
Ibn Sina Pharma close to launching Al Shorouk Hospital 🚪
Health & Pharma💉

Ibn Sina Pharma close to launching Al Shorouk Hospital 🚪

by Omar El Shorafa
January 19, 2023
Two state-owned companies prepping for an IPO 🔔
EGX 🔔

Two state-owned companies prepping for an IPO 🔔

by Omar El Shorafa
January 17, 2023
Will we see an increase in the price of medicines? ⚕️
Health & Pharma💉

Will we see an increase in the price of medicines? ⚕️

by Omar El Shorafa
January 17, 2023

Website

Community

Blog

Learn

© Thndr. All rights reserved

No Result
View All Result
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic

Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved

 

Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.

This is why we introduced Thndr Thinkers💭

Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!

Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts 

Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!

Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours 

Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.

Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers 

No promotional content🚫 We don’t publish promotional content.

Any questions about becoming a Thndr Thinker? Email thndrclaps@thndr.app and we’d be happy to help!

Normally, your article will be published within 24 hours of submission (if you followed the guidelines)